Separation of mediastinal shed blood during aortic valve surgery elicits a reduced inflammatory response

Aims The detrimental effects of inflammation following cardiopulmonary bypass (CPB) could negatively affect the postoperative outcome in a specific subset of high-risk patients. We therefore investigated the impact of a CPB circuit (Admiral, Eurosets, Italy) that allows separation of intracavitary and mediastinal blood on the release of biochemical markers and clinical outcome when compared with a conventional circuit. Methods Thirty patients undergoing aortic valve surgery were prospectively enrolled and assigned to Admiral group (Group 1, G1, n = 15) or conventional CPB group (Group 2, G2, n = 15). The Admiral oxygenator allows for a separate collection of mediastinal blood processed through a cell-saver before retransfusion. Clinical data and biochemical parameters were measured preoperatively, during CPB and at different time-points postoperatively. Results Preoperative demographics, intraoperative data (as CPB and aortic cross-clamping time) and perioperative complications did not differ between groups. Inflammatory response was significantly decreased in G1, as assessed by means of D-dimer (G1 = 1332.3 ± 953.9 vs. G2 = 2791.9 ± 1740.7 ng/ml, P = 0.02), C-reactive protein (G1 = 169.1 ± 164.8 vs. G2 = 57.1 ± 39.3 mg/l, P = 0.04), interleukin-6 (G1 = 11.8 ± 12.5 vs. G2 = 26.5 ± 24.9 pg/ml, P = 0.02) and tumour necrosis factor-alpha (G1 = 29 ± 28.7 vs. G2 = 45.5 ± 23.6 pg/ml, P = 0.03). Conclusion Although no considerable difference was detected in terms of perioperative outcomes, the Admiral oxygenator did result in a significant reduction of inflammatory markers during the early postoperative course.

[1]  H. Muhammad,et al.  Effect of ulinastatin on perioperative organ function and systemic inflammatory reaction during cardiac surgery: a randomized double-blinded study , 2013, Korean journal of anesthesiology.

[2]  Gang Wang,et al.  Combined treatment of ulinastatin and tranexamic acid provides beneficial effects by inhibiting inflammatory and fibrinolytic response in patients undergoing heart valve replacement surgery. , 2013, The heart surgery forum.

[3]  R. Whistance,et al.  The Inflammatory Response to Miniaturised Extracorporeal Circulation: A Review of the Literature , 2010, Mediators of inflammation.

[4]  Yasuhiko Kobayashi,et al.  Minimal cardiopulmonary bypass attenuates neutrophil activation and cytokine release in coronary artery bypass grafting , 2007, Journal of Artificial Organs.

[5]  O. Ponzio,et al.  Comparison of the inflammatory response between miniaturized and standard CPB circuits in aortic valve surgery. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[6]  A. Markewitz,et al.  Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know? , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  E. Kunesch,et al.  Evaluation of coated oxygenators in cardiopulmonary bypass systems and their impact on neurocognitive function , 2005, Perfusion.

[8]  O. Ponzio,et al.  Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  T. Yau,et al.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  X. Bossuyt,et al.  Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass , 2002, Perfusion.

[11]  M. Underwood,et al.  Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. , 2000, The Annals of thoracic surgery.

[12]  K. Taylor,et al.  Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules. , 1998, The Annals of thoracic surgery.

[13]  A. Serraf,et al.  Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations. , 1996, The Journal of thoracic and cardiovascular surgery.

[14]  D. Mann,et al.  Expression and functional significance of tumor necrosis factor receptors in human myocardium. , 1995, Circulation.

[15]  J. Jespersen,et al.  Enhanced Effective Fibrinolysis following the Neutralization of Heparin in Open Heart Surgery Increases the Risk of Post-Surgical Bleeding , 1990, Thrombosis and Haemostasis.

[16]  Xiang Xiaoyong,et al.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment , 2005 .

[17]  D. Shale,et al.  Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. , 1993, The Journal of thoracic and cardiovascular surgery.

[18]  E. Merrill,et al.  Does the conformation of adsorbed fibrinogen dictate platelet interactions with artificial surfaces? , 1986, Blood.